Plan d’Action Luxembourgeois de réduction du Mésusage de l’Alcool (PALMA)

Public Health Health Action Plan 2020
Luxembourg French PDF
National

AI-Generated Document Summary

Objectives

Luxembourg’s 2020–2024 Action Plan to Reduce Alcohol Misuse, known as PALMA, provides a national framework to prevent and improve management of alcohol misuse, reduce associated health, social and economic harm, and lower alcohol-related morbidity, premature mortality and dependence.It seeks to foster healthy and reasonable alcohol-related behaviours across the life course, with particular protection for young people, pregnant and breastfeeding women, and other groups at increased risk.

  • Strengthen governance, shared responsibility and coordinated national action involving public authorities, civil society, health professionals and partners outside the health sector.
  • Promote health and prevent harmful consumption through accessible information, supportive environments, life skills, prevention of addiction and targeted action for young people and workplaces.
  • Adapt regulation of alcohol availability, distribution, advertising, marketing and young people’s access, while reinforcing road-safety measures addressing drink-driving and compliance with legal requirements.
  • Improve early identification of harmful alcohol use, brief intervention and referral, with the objective of reducing progression towards dependence.
  • Develop an accessible, evidence-based continuum of therapeutic care, rehabilitation, harm reduction and support for relatives, from detection to long-term accommodation where required.
  • Build professional competence through initial and continuing training, and strengthen research on population-specific risk factors and young people’s drinking patterns.

The plan is aligned with World Health Organization and European approaches that support multisectoral action, individual capacity-building and healthier environments.It also seeks synergies with national cancer, cardio-neurovascular disease and mental-health plans.PALMA identifies six principal axes: governance; health promotion and prevention; early screening and brief interventions; care pathways, rehabilitation and harm reduction; professional training; and research.

Its quantified ambitions include halving alcohol consumption in the general population by 2024, particularly among young people and pregnant women; reducing foetal alcohol syndrome, alcohol-related road harm and admissions for acute intoxication; and increasing occupational physicians’ referrals to advice and orientation services.The source also identifies a target to halve the proportion of pregnant women consuming alcohol by 2022.

Implementation

PALMA is to be implemented through an interministerial, interdisciplinary and intersectoral National PALMA Platform, appointed by the Council of Government and supported by a coordinator.The platform is intended to implement, coordinate, monitor and evaluate the plan, draw on experts where necessary, define data-collection procedures and support adjustments in response to progress and evidence.

  • Establish the platform, appoint the coordinator, adopt its establishing regulation and convene its first official meeting within three months of government approval.
  • Disseminate PALMA through partner channels, conferences, social media, a dedicated website and an annual national day on reducing alcohol misuse.
  • Map prevention, detection, treatment, rehabilitation and support services, including admission conditions and care pathways; publish the map by the end of 2021 and update it regularly.
  • Apply systematic controls to alcohol sales and distribution, road traffic, advertising and marketing, and enforce statutory sanctions.
  • Deliver multilingual information, awareness campaigns, conferences, dialogue activities and targeted guidance for people at risk, relatives, employers and young people.
  • Provide Health Corners and prevention resources in schools, youth settings, childcare facilities, medical practices, enterprises and occupational health services.

Early detection is to be embedded in public-health assessments, general and primary care, occupational and school health, hospital care and sports medicine.PFN-PALMA is assigned to select scientifically validated screening guidance for the general population and specific groups, submit guidance to the Scientific Council in the Health Field, maintain a literature watch and support dissemination to professionals.Delivery tools include validated assessment grids, decision trees, guidance linked to screening scores, online self-screening for adults and people under 16, and information on referral services.

Care delivery is intended to combine regional advice and orientation services, hospital addiction liaison teams, outreach provision, day hospitals, outpatient programmes, inpatient rehabilitation, low-threshold care and specialised accommodation.Hospital and non-hospital actors are to coordinate through multidisciplinary networks, shared care records, transfer plans and discharge plans, while a pilot case-management model is to support people with addiction and psychological or physical comorbidities.Care should comply with the 24 July 2014 law on patients’ rights and obligations and preserve patients’ freedom to choose their doctor and care structure.

Professional capacity-building covers prevention, screening, brief intervention, motivational interviewing, therapeutic care, relapse prevention and recognition of cognitive, physical, psychiatric and social effects of chronic alcohol misuse.Relevant institutional continuing-education programmes are expected to provide at least one alcohol-related activity annually, with targets for 80% of relevant personnel to be trained and for alcohol-related content to represent 10% of annual continuing-training hours by 2024.Research is envisaged with the University of Luxembourg, research centres and addiction-care organisations, potentially financed through national, European, Interreg, private or Directorate of Health mechanisms.

Monitoring is based on robust indicators covering outcomes, quality, process and performance, supported by an information system and annual public activity reporting.Planned outputs include a first epidemiological report in 2023, annual and five-year epidemiological reporting, a mid-term external evaluation at the end of 2022, and a final external evaluation to inform a possible successor plan.The source does not provide a quantified overall PALMA budget; financing actions focus instead on reviewing reimbursement, hospital budgets, professional nomenclatures and alternative mechanisms for care, accommodation, training and research.

Monitoring & Evaluation

PALMA 2020–2024 establishes a monitoring and evaluation system intended to measure public-health impact, guide implementation and support adjustment of actions through relevant, valid and robust indicators and an effective information system.Overall success is to be assessed using epidemiological and socio-economic measures, including alcohol-attributable mortality and morbidity, age at first alcohol use among young people, work absences, disability and hospitalisations.

  • Establish a National PALMA Platform, supported by a coordinator, to implement, coordinate, monitor and evaluate the plan; the coordinator is responsible for tracking progress, reporting to the platform and proposing adjustments.
  • Appoint the coordinator, adopt the regulation establishing the platform and convene its first official meeting within three months of government approval.
  • Define indicator specifications, data requirements and data producers; organise collection, improve tools where necessary, train providers and validate data quality.
  • Expand indicators to cover outcomes, quality, processes and performance, allowing regular adaptation of the action plan.
  • Analyse longitudinal trends and benchmarking through the National Health Observatory or another body to be determined.
  • Publish annual public activity reports on implementation progress, difficulties and unresolved critical issues, supported by transparent exchange among field actors, funders and public authorities.
  • Produce annual and five-year epidemiological reports, with the first epidemiological report scheduled for 2023; the source also describes an epidemiological report every five years to assess the plan’s impact.
  • Undertake an external mid-term evaluation at the end of 2022 and a larger external evaluation at the end of PALMA, with results and recommendations published for citizens, professionals and public authorities.

Monitoring encompasses implementation milestones, care pathways, prevention, regulatory compliance, screening, service availability and professional capacity. A publicly available map of health-promotion, prevention, detection and care services is to be published by the end of 2021 and updated regularly.Screening monitoring includes use of validated guidelines and a screening grid in health contacts, implementation of systematic screening, online self-screening use and a referral-recording system to be established in 2022.One target is assessment for harmful alcohol use among 50% of people covered by Action 3.2.1.

  • Monitor reductions in alcohol consumption, foetal alcohol syndrome, alcohol-related road accidents and deaths, acute intoxication admissions, and increased occupational-physician referrals to support services.
  • Use the PERINAT register for foetal alcohol syndrome incidence and target a halving by 2022 of the proportion of pregnant women consuming alcohol.
  • Apply systematic compliance checks, review control processes and responsible bodies, adapt procedures to legislative changes, and enforce statutory sanctions.
  • Evaluate implementation of good-practice guidelines, the case-management pilot and care-network functioning to identify and resolve critical points in patient care.
  • Track annual alcohol-related continuing-training provision, target training for 80% of relevant workers by 2024, and target alcohol-related content for 10% of annual continuing-training hours across health professions by 2024.
  • Monitor research through funding and commencement of projects in 2021 and progress on initial findings in 2022.

Baseline evidence includes the 2014 European Health Interview Survey, hospital billing data and social-security calculations.Interpretation of alcohol-per-capita consumption requires caution because alcohol sales to non-residents are substantial; cited World Health Organization estimates therefore used an average of French and German consumption figures.The source does not fully specify indicator definitions, data governance, reporting responsibilities, surveillance architecture or accountability procedures beyond the described platform, reports, milestones, targets and compliance controls.

Costing & Financing

PALMA includes a projected 2020–2024 budget structured by year and action axis, but the supplied material provides no monetary totals, allocations or detailed expenditure lines.Harmful alcohol use is recognised as generating individual and collective costs through dependence, comorbidities and premature mortality, without monetary estimates.

  • Increase financial resources for prevention and care, as encouraged by the international policy orientations referenced in the plan.
  • Assess, with the National Health Fund, whether reimbursement nomenclature can support evidence-based pharmacological and non-pharmacological therapies.
  • Identify alcohol-care activities outside existing financing systems, determine suitable financing mechanisms and consider alternative models for professional care activities.
  • Develop financing arrangements for medical and nursing consultations delivered by hospital addiction liaison teams, in discussion with the National Health Fund.
  • Establish financing mechanisms for medium- and long-stay rehabilitation accommodation and accommodation for people who require care without seeking detoxification.
  • Organise professional-activity financing through hospital budgets or professional nomenclatures, subject to legal bases, applicable procedures and the Social Security Code.
  • Mobilise potential research funding through the National Research Fund, European and Interreg programmes, private funds, foundations and the Directorate of Health.

The source identifies resource needs for training, educational materials, screening tools, communication campaigns, service mapping, care networks, rehabilitation capacity and research, but does not quantify these requirements.No funding gap, economic assumption, unit cost, exchange rate, total budget or confirmed funding allocation is specified in the supplied extracts.

Document Viewer